Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by Ab oligomers
Morgado, J.; Diniz, L. P.; Araujo, A. P. B.; Antonio, L. M. d. S.; Araujo, H. P. M.; Pinheiro, P. d. S. M.; Sagrillo, F. S.; Cesar, G. V.; Ferreira, S. T.; Figueiredo, C. P.; Fraga, C. A. M.; GOMES, F. C. A.
Show abstract
Inhibitors of histone deacetylases (iHDACs) are promising drugs for neurodegenerative diseases. We have evaluated the therapeutic potential of the new iHDAC6 LASSBio-1911 in A{beta} oligomer (A{beta}O) toxicity models and astrocytes, key players in neuroinflammation and Alzheimers disease (AD). Astrocyte phenotype and synapse density were evaluated by flow cytometry, Western blotting, immunofluorescence and qPCR, in vitro and in mice. Cognitive function was evaluated by behavioural assays using a mouse model of intracerebroventricular infusion of A{beta}O. LASSBio-1911 modulates reactivity and synaptogenic potential of cultured astrocytes and improves synaptic markers in cultured neurons and in mice. It prevents A{beta}O-triggered astrocytic reactivity in mice and enhances the neuroprotective potential of astrocytes. LASSBio-1911 improves behavioural performance and rescues synaptic and memory function in A{beta}O-infused mice. These results contribute to unveiling the mechanisms underlying astrocyte role in AD and provide the rationale for using astrocytes as targets to new drugs for AD.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Forebrain-specific loss of erythropoietin provokes compensatory upregulation of different EPO receptors 94%
- Frontotemporal dementia patient-derived iPSC neurons show cell pathological hallmarks and evidence for synaptic dysfunction and DNA damage 94%
- Alzheimer's Disease Patient Brain Extracts Induce Multiple Pathologies in Vascularized Neuroimmune Organoids for Disease Modeling and Drug Discovery 94%
Similar papers in this journal
- Social and Contextual Memory Impairments Induced by Amyloid-β Oligomers are Rescued by Sigma-1 Receptor Activation 96%
- Drug repurposing of dopaminergic drugs to inhibit Ataxin-3 aggregation 93%
- Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition 93%
Similar papers in this journal
- Hyperphosphorylated Tau Inflicts Intracellular Stress Responses That Are Mitigated by Apomorphine 96%
- NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer's disease 96%
- Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-Inflammatory Signalling Cues and Inhibit Phagocytosis 95%
Similar papers in this journal
- Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice 95%
- Kappa opioid receptor induces epigenetic silencing of brain derived neurotropic factor via HDAC5 in treatment-resistant depression 94%
- A patient-derived blood-brain barrier model for screening copper bis(thiosemicarbazone) complexes as potential therapeutics in Alzheimer's disease 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.